NETRF Pilot Award Program: Early Detection Request for Applications

This RFA supports research aimed at earlier, more accurate detection of NENs (neuroendocrine neoplasms) , precursor or premalignant lesions, and recurrence or progression in defined clinical or high-risk settings. NETRF is particularly interested in approaches that can be developed and validated in populations where disease risk, clinical suspicion, or recurrence risk is sufficiently elevated to support feasible and actionable early detection.

Research Authority due date: 8.6.26

LOI (required) due date: 15.6.26

Full propםsal due date: 6.10.26